Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Merck Europe B.V., against the decision of the State Institute for Drug Control from 30. 12. 2020, under the no.: SUKLS81993/2020:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance companies, against the decision of the State Institute for Drug Control from 14. 12. 2021, under the no. SUKLS312222/2021:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Merck spol. s r.o., against the decision of the State Institute for Drug Control from 13. 11. 2020, under the no.: SUKLS98270/2020:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance companies, against the decision of the State Institute for Drug Control from 31. 12. 2020, under the no. SUKLS305970/2020:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance companies, against the decision of the State Institute for Drug Control from 7. 5. 2021, under the no. SUKLS104263/2021:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance companies, against the decision of the State Institute for Drug Control from 8. 7. 2021, under the no. SUKLS170270/2021:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Amgen Europe B.V., against the decision of the State Institute for Drug Control from 14. 1. 2022, under the no. SUKLS1178/2022:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance companies, against the decision of the State Institute for Drug Control from 12. 5. 2021, under the no. SUKLS252032/2017:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.